Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,040 | 7,241 | 555 | N/A | N/A |
| TOTAL | $15,496 | $7,894 | $588 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 23 | 18 | N/A | N/A | N/A |
| Other Non-Current Assets | 334 | 0 | 95 | 0 | 0 |
| TOTAL | $358 | $18 | $95 | $N/A | $N/A |
| Total Assets | $15,853 | $7,912 | $683 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 282 | N/A | N/A |
| Accounts payable and accrued liabilities | 946 | 290 | 129 | 0 | 0 |
| Accrued Expenses | 520 | 22 | 24 | N/A | N/A |
| Other current liabilities | N/A | N/A | 763 | N/A | N/A |
| TOTAL | $1,905 | $311 | $1,233 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,905 | $311 | $1,233 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 24 | 17 | 13 | N/A | N/A |
| Retained earnings | -20,946 | -11,489 | -7,611 | N/A | N/A |
| TOTAL | $13,948 | $7,601 | $-549 | $N/A | $N/A |
| Total Liabilities And Equity | $15,853 | $7,912 | $683 | $0 | $0 |